Initial Disclosure Notice – Kathryn Waugh

Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013

To NZX Limited; and ASX
Name of listed issuer: Oceania Healthcare Limited
Date this disclosure made: 18 May 2021
Date on which issuer listed or appointment made: 13 May 2021

Director or senior manager giving disclosure
Full name(s): Kathryn Waugh
Name of listed issuer: Oceania Healthcare Limited
Name of related body corporate (if applicable): N/A
Position held in listed issuer: Chief Financial Officer

Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product: Ordinary shares
Number held in class: 11,834
Nature of relevant interest:
Registered and beneficial owner
of shares
Current registered holder: Kathryn Waugh

Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product: Ordinary shares
Number held in class: 1,546
Nature of relevant interest: Beneficial interest in shares
issued under the terms of the
Oceania Healthcare Employee
Share Scheme, under which
shares are held by OCA
Employees Trustee Limited
Current registered holder: OCA Employees Trustee Limited

Summary of specified derivatives relevant interest (if applicable)
Type of derivative: N/A
Class of underlying financial products: N/A

Details of derivative

The notional value of the derivative (if any) or the notional
amount of underlying products (if any):
N/A
A statement as to whether the derivative is cash settled or
physically settled:
N/A
Maturity date of the derivative (if any): N/A
Expiry date of the derivative (if any): N/A
The price specified in the terms of the derivative (if any): N/A
Any other details needed to understand how the amount of
the consideration payable under the derivative or the value
of the derivative is affected by the value of the underlying
financial products:
N/A
For that derivative: -
Parties to the derivative: N/A
If the director or senior manager is not a party to the
derivative, the nature of the relevant interest in the
derivative:
N/A

Certification
I certify that, to the best of my knowledge and belief, the
information contained in this disclosure is correct and that I
am duly authorised to make this disclosure by all persons
for whom it is made.

Signature of director or officer:

Date of signature:
or
Signature of person authorised to sign on behalf of director
or officer:


Date of signature: 18 May 2021
Name and title of authorised person: Anna Thorburn
General Counsel & Company
Secretary